What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Cancer
Mark Crowther spends much of his time researching Surgery, Internal medicine, Thrombosis, Randomized controlled trial and Anticoagulant.
His Surgery study combines topics in areas such as Incidence and Warfarin.
His research integrates issues of Pulmonary embolism, Radiology, Heparin and Hazard ratio in his study of Thrombosis.
His Randomized controlled trial study incorporates themes from Placebo, Anesthesia, Clinical trial and Venous thromboembolism.
His Anticoagulant research integrates issues from Chemoprophylaxis, Complication and Intensive care medicine.
The various areas that Mark Crowther examines in his Intensive care medicine study include MEDLINE, Adverse effect, Prothrombin complex concentrate, Evidence-based practice and Apixaban.
His most cited work include:
- Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (5057 citations)
- Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (1747 citations)
- The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (1234 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Surgery, Thrombosis, Intensive care medicine and Warfarin.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Gastroenterology.
His work on Incidence expands to the thematically related Surgery.
His studies in Thrombosis integrate themes in fields like Antithrombotic and Hazard ratio.
Factor Xa Inhibitor is closely connected to Rivaroxaban in his research, which is encompassed under the umbrella topic of Intensive care medicine.
In his study, Dabigatran is inextricably linked to Anesthesia, which falls within the broad field of Warfarin.
He most often published in these fields:
- Internal medicine (37.94%)
- Surgery (35.43%)
- Thrombosis (25.25%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (37.94%)
- Surgery (35.43%)
- Randomized controlled trial (17.21%)
In recent papers he was focusing on the following fields of study:
Mark Crowther focuses on Internal medicine, Surgery, Randomized controlled trial, Thrombosis and Rivaroxaban.
Internal medicine is closely attributed to Gastroenterology in his study.
His study brings together the fields of MEDLINE and Surgery.
The concepts of his Randomized controlled trial study are interwoven with issues in Cancer, Clinical trial, Relative risk, Anticoagulant and Hazard ratio.
His work in Thrombosis addresses issues such as Pulmonary embolism, which are connected to fields such as Deep vein.
Mark Crowther has researched Rivaroxaban in several fields, including Dabigatran and Intensive care medicine.
Between 2015 and 2021, his most popular works were:
- Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors (507 citations)
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. (365 citations)
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. (365 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Cancer
The scientist’s investigation covers issues in Internal medicine, Surgery, Randomized controlled trial, Rivaroxaban and Thrombosis.
His specific area of interest is Surgery, where Mark Crowther studies Enema.
His research in Randomized controlled trial intersects with topics in Clostridium difficile, Red blood cell, Enterocolitis, Infection control and Hazard ratio.
His Rivaroxaban study also includes fields such as
- Dabigatran, which have a strong connection to Intensive care medicine,
- Aspirin which intersects with area such as Arthroplasty.
The concepts of his Thrombosis study are interwoven with issues in Gastroenterology, Pulmonary embolism and Clinical trial.
In his study, Stroke and Lower risk is strongly linked to Warfarin, which falls under the umbrella field of Anticoagulant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
